DRUG
Bright Minds Biosciences Inc
53.50$
-7.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +1,100.1% | +1.3% | +4.8% | |
| – | – | +445.9% | -0.6% | +31.7% | -27.1% | +279.0% | |
| – | +0.0% | +535.7% | -36.8% | – | – | – | |
| – | -16.4% | +897.5% | +136.6% | -230.0% | – | +1,294.0% | |
| – | – | – | – | – | -100.0% | – | |
| – | +0.0% | +0.0% | +0.0% | +1,102.3% | +4.2% | +11.6% | |
| – | +726.5% | +2,484.0% | -80.1% | -57.9% | -63.0% | +10,456.4% | |
| – | +800.0% | +2,533.6% | -142.9% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.